Status:
UNKNOWN
Prophylactic Amiodarone for Shockable Cardiac Arrest
Lead Sponsor:
Won Young Kim
Conditions:
Cardiac Arrest
Ventricular Arrythmia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The aim of this study is to determine whether the prophylactic amiodarone can prevent re-arrest with ventricular shockable rhythm in patients who treated with targeted temperature management after ret...
Detailed Description
Patients with cardiac arrest are in high risk of re-arrest during post cardiac arrest care due to vulnerable heart state electrically and hemodynamically. Especially if patients who had experienced sh...
Eligibility Criteria
Inclusion
- Non traumatic cardiac arrest patients who had VF or pVT during CPR in ER
Exclusion
- age \< 18 yr
- pregnancy
- non cardiac caused arrest such as hanging
- previous amiodarone continuous infusion before radomization
- sustained ventricular arrhythmia recurrence after ROSC
- extracorporeal membrane oxygenation
- contra indication for amiodarone
- disagree with this research
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT04845607
Start Date
April 1 2021
End Date
February 28 2023
Last Update
June 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 05505